Sugamet SR (evogliptin/metformin)
/ Dong-A
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
February 22, 2023
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Dong-A ST Co., Ltd.
New P1 trial
February 22, 2023
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Dong-A ST Co., Ltd.
New P1 trial
February 22, 2023
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
(clinicaltrials.gov)
- P1 | N=34 | Not yet recruiting | Sponsor: Dong-A ST Co., Ltd.
New P1 trial
February 22, 2023
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
(clinicaltrials.gov)
- P1 | N=34 | Not yet recruiting | Sponsor: Dong-A ST Co., Ltd.
New P1 trial
May 20, 2020
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State
(clinicaltrials.gov)
- P1; N=30; Completed; Sponsor: Dong-A ST Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
May 20, 2020
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State
(clinicaltrials.gov)
- P1; N=34; Completed; Sponsor: Dong-A ST Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 6
Of
6
Go to page
1